LIVER CIRRHOSIS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-23315 | Health Care
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Liver Cirrhosis Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL LIVER CIRRHOSIS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL LIVER CIRRHOSIS MARKET
7.1 GLOBAL LIVER CIRRHOSIS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL LIVER CIRRHOSIS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL LIVER CIRRHOSIS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA LIVER CIRRHOSIS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 F. Hoffmann-La Roche AG (Switzerland)
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Merck & Co., Inc (United States)
16.3 Abbott Laboratories (United States)
16.4 Novartis International AG (Switzerland)
16.5 Bristol Myers Squibb Company (United States)
16.6 Gilead Sciences, Inc (United States)
16.7 Conatus Pharmaceuticals (United States)
16.8 GlaxoSmithKline plc (United Kingdom)
16.9 Grifols, S.A. (Spain)
16.10 GWOXI Stem Cell Applied Technology Co., Ltd (China)
16.11 Hepion Pharmaceuticals (United States)
16.12 Intercept Pharmaceuticals, Inc. (United States)
16.13 Lepu Medical Technology (Beijing) Co., Ltd. (China)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeAlcoholic Cirrhosis
Atrophic Cirrhosis
Biliary Cirrhosis
Cardiac Cirrhosis
Cryptogenic Cirrhosis
By Application
Hospitals
Specialty Clinics
Others
By Treatment
Self-care
Medications {Diuretic Ammonia Reducer Beta Blocker Antibiotics Antiviral Drug}
Medical procedure {Rubber Band Ligation Therapeutic Endoscopy and Transjugular Intrahepatic Portosystemic Shunt}
Surgery {Liver transplantation}
By Stages
Stage 1
Stage 2
Stage 3
Stage 4
By Tests
Computed Tomography (CT)
Ultrasound
Magnetic Resonance Imaging (MRI)
Needle Biopsy
Companies
F. Hoffmann-La Roche AG (Switzerland)
Merck & Co., Inc (United States)
Abbott Laboratories (United States)
Novartis International AG (Switzerland)
Bristol Myers Squibb Company (United States)
Gilead Sciences, Inc (United States)
Conatus Pharmaceuticals (United States)
GlaxoSmithKline plc (United Kingdom)
Grifols, S.A. (Spain)
GWOXI Stem Cell Applied Technology Co., Ltd (China)
Hepion Pharmaceuticals (United States)
Intercept Pharmaceuticals, Inc. (United States)
Lepu Medical Technology (Beijing) Co., Ltd. (China)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.